Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novocure Ltd.

www.novocure.com

Latest From Novocure Ltd.

US FDA Greenlights First-In-Kind Diagnostics, Device

The US Food and Drug Administration recently approved several first-of-a-kind diagnostics and a medical device, including a test kit for prosthetic joint infections, a Zika virus test and an electric field device to treat cancers.

Regulation Approvals

Higher Doses Of Novocure’s TTF Help New Glioblastoma Patients

The first reported analysis demonstrating a patient-level dose response with Novocure’s Tumor Treating Fields therapy is now published. The post-hoc analysis of the EF-14 trial showed higher doses of Tumor Treating Fields improved survival in newly diagnosed glioblastoma patients.

Clinical Trials Cancer

NovoCure’s Tumor Treating Fields Help Mesothelioma Patients Live Longer In STELLAR Trial

New results from the Phase II STELLAR trial shows Tumor Treating Fields therapy in conjunction with chemotherapy extends survival in previously untreated mesothelioma patients with no safety problems.

Clinical Trials Research & Development

Novocure Launches INNOVATE 3 Trial Of Ovarian Cancer Therapy

INNOVATE 3 is a phase 3 pivotal trial testing the efficacy of Novocure's Tumor Treating Fields therapy combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer.

Starts & Stops Tracking Trials
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Standen Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Novocure Ltd.
  • Senior Management
  • Asaf Danziger, CEO
    Wilco Groenhuysen, CFO
    Mike Ambrogi, COO
    Eilon Kirson, MD, PhD, Head, R&D & CSO
    Pritesh Shah, Chief Commercial Officer
  • Contact Info
  • Novocure Ltd.
    Phone: (972) 15 3475 6700
    No. 4 The Forum, Grenville St.
    St. Helier
    Jersey , JE2 4UF
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register